BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32713720)

  • 1. Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients.
    Anderson LJ; Lee J; Mallen MC; Migula D; Liu H; Wu PC; Dash A; Garcia JM
    Clin Nutr; 2021 Mar; 40(3):978-986. PubMed ID: 32713720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle mass, not radiodensity, predicts physical function in cancer patients with or without cachexia.
    Anderson LJ; Chong N; Migula D; Sauer A; Garrison M; Wu P; Dash A; Garcia JM
    Oncotarget; 2020 May; 11(20):1911-1921. PubMed ID: 32499874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia.
    Burney BO; Hayes TG; Smiechowska J; Cardwell G; Papusha V; Bhargava P; Konda B; Auchus RJ; Garcia JM
    J Clin Endocrinol Metab; 2012 May; 97(5):E700-9. PubMed ID: 22419719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the criteria for response to cachexia treatment?
    Crawford J
    Ann Palliat Med; 2019 Jan; 8(1):43-49. PubMed ID: 30685983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
    Ramage MI; Skipworth RJE
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):439-444. PubMed ID: 30138131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women.
    Wright TJ; Dillon EL; Durham WJ; Chamberlain A; Randolph KM; Danesi C; Horstman AM; Gilkison CR; Willis M; Richardson G; Hatch SS; Jupiter DC; McCammon S; Urban RJ; Sheffield-Moore M
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):482-496. PubMed ID: 29654645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring cachexia-diagnostic criteria.
    Dev R
    Ann Palliat Med; 2019 Jan; 8(1):24-32. PubMed ID: 30525765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body weight changes and incidence of cachexia after stroke.
    Scherbakov N; Pietrock C; Sandek A; Ebner N; Valentova M; Springer J; Schefold JC; von Haehling S; Anker SD; Norman K; Haeusler KG; Doehner W
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):611-620. PubMed ID: 30680953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The abridged patient-generated subjective global assessment is a useful tool for early detection and characterization of cancer cachexia.
    Vigano AL; di Tomasso J; Kilgour RD; Trutschnigg B; Lucar E; Morais JA; Borod M
    J Acad Nutr Diet; 2014 Jul; 114(7):1088-1098. PubMed ID: 24462323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle mass, quality, and strength; physical function and activity; and metabolic status in cachectic patients with head and neck cancer.
    Ohmae N; Yasui-Yamada S; Furumoto T; Wada K; Hayashi H; Kitao M; Yamanaka A; Kubo M; Matsuoka M; Kamimura S; Shimada A; Sato N; Kitamura Y; Katoh S; Takeda N; Hamada Y
    Clin Nutr ESPEN; 2023 Feb; 53():113-119. PubMed ID: 36657901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a leucine-rich supplement in combination with nutrition and physical exercise in advanced cancer patients: A randomized controlled intervention trial.
    Storck LJ; Ruehlin M; Gaeumann S; Gisi D; Schmocker M; Meffert PJ; Imoberdorf R; Pless M; Ballmer PE
    Clin Nutr; 2020 Dec; 39(12):3637-3644. PubMed ID: 32340904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients.
    Lemmey AB; Wilkinson TJ; Clayton RJ; Sheikh F; Whale J; Jones HS; Ahmad YA; Chitale S; Jones JG; Maddison PJ; O'Brien TD
    Rheumatology (Oxford); 2016 Oct; 55(10):1736-45. PubMed ID: 27288209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand grip strength in patients with advanced cancer: A prospective study.
    Hadzibegovic S; Porthun J; Lena A; Weinländer P; Lück LC; Potthoff SK; Rösnick L; Fröhlich AK; Ramer LV; Sonntag F; Wilkenshoff U; Ahn J; Keller U; Bullinger L; Mahabadi AA; Totzeck M; Rassaf T; von Haehling S; Coats AJS; Anker SD; Roeland EJ; Landmesser U; Anker MS
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1682-1694. PubMed ID: 37318103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients.
    Wallengren O; Lundholm K; Bosaeus I
    Support Care Cancer; 2013 Jun; 21(6):1569-77. PubMed ID: 23314651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).
    Crawford J; Prado CM; Johnston MA; Gralla RJ; Taylor RP; Hancock ML; Dalton JT
    Curr Oncol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meaningful measures in cancer cachexia: implications for practice and research.
    McDonald JJ; Fallon MT; Laird BJA
    Curr Opin Support Palliat Care; 2019 Dec; 13(4):323-327. PubMed ID: 31599817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of anaerobic capacity in adults with growth hormone deficiency.
    Chikani V; Cuneo RC; Hickman I; Ho KK
    J Clin Endocrinol Metab; 2015 May; 100(5):1811-8. PubMed ID: 25695894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endpoints in clinical trials in cancer cachexia: where to start?
    Laird BJA; Balstad TR; Solheim TS
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):445-452. PubMed ID: 30299325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial.
    Sattler F; Bhasin S; He J; Chou CP; Castaneda-Sceppa C; Yarasheski K; Binder E; Schroeder ET; Kawakubo M; Zhang A; Roubenoff R; Azen S
    J Gerontol A Biol Sci Med Sci; 2011 Jan; 66(1):122-9. PubMed ID: 21059836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
    McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.